EUVIMEDEUVIMED entdecken
Open Access

Clinical efficacy of recombinant human bone morphogenetic protein-2 loaded acellular dermal matrix for horizontal ridge augmentation

H Seo, H Pak, E Park, J Son

Medicina Oral Patología Oral y Cirugia Bucal · 2026 · e882-e890

DOI: 10.4317/medoral.28313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicina Oral Patología Oral y Cirugia Bucal, 2026. Verfasst von H Seo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Jang Ho Son Department of Oral and Maxillofacial Surgery, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Kore…. Hauptthemen laut MEDLINE: Bone Morphogenetic Protein 2, Acellular Dermis, Transforming Growth Factor beta, Alveolar Ridge Augmentation. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Implant placement often presents challenges owing to presence of inadequate horizontal bone volume, particularly in cases with periodontitis, trauma, pathology, or long-term tooth loss. Horizontal ridge augmentation (HRA) is essential for proper implant positioning and long-term success. This study evaluated clinical and radiographic outcomes of HRA using acellular dermal matrix (ADM) loaded with recombinant human bone morphogenetic protein-2 (rhBMP-2) during dental implant placement. MATERIALS AND METHODS: We retrospectively analyzed patients who underwent HRA with rhBMP-2-soaked ADM during implant surgery. Outcomes included cone beam computed tomography (CBCT)-based bone formation at 5 months, peri-implant complications, and effect of fixation screw placement. Patients were categorized into two groups: those with ADM graft fixation and those without. RESULTS: The augmented bone width was compared using CBCT. Overall, 21 implant sites were evaluated in 18 patients. Mean horizontal bone gain was 1.3 ± 0.7 mm at the crestal level, 1.4 ± 0.8 mm at 1 mm, and 1.0 ± 0.9 mm at 2 mm apical to the cover screw. Sites with a fixation screw showed significantly greater gain (1.9 ± 0.6 mm, 1.8 ± 1.0 mm, and 1.5 ± 1.0 mm) than those without a screw (0.9 ± 0.4 mm, 1.2 ± 0.6 mm, and 0.7 ± 0.6 mm; P < 0.05). All implants remained clinically stable with no compromised peri-implant health during a mean functional loading period of 18 ± 12.5 months. CONCLUSIONS: The rhBMP-2-loaded ADM graft provides favorable horizontal bone gain while maintaining healthy peri-implant tissue conditions during the observed loading period, offering a minimally invasive alternative for managing horizontal alveolar deficiencies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Morphogenetic Protein 2Acellular DermisTransforming Growth Factor betaAlveolar Ridge AugmentationHumansRecombinant ProteinsRetrospective StudiesFemaleMaleMiddle AgedTreatment OutcomeAdultAged

Substanzen

Bone Morphogenetic Protein 2Recombinant ProteinsTransforming Growth Factor betarecombinant human bone morphogenetic protein-2

Autor:innen und Institutionen

  • Jang Ho Son Department of Oral and Maxillofacial Surgery, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea. 877 Bangeojinsunwhandoro, Dong-gu, Ulsan 44033, Republic of Korea r…

Zitieren

APA

Seo, H., Pak, H., Park, E., & Son, J. (2026). Clinical efficacy of recombinant human bone morphogenetic protein-2 loaded acellular dermal matrix for horizontal ridge augmentation. Medicina Oral Patología Oral y Cirugia Bucal, e882-e890. https://doi.org/10.4317/medoral.28313

Vancouver

Seo H, Pak H, Park E, Son J. Clinical efficacy of recombinant human bone morphogenetic protein-2 loaded acellular dermal matrix for horizontal ridge augmentation. Medicina Oral Patología Oral y Cirugia Bucal. 2026:e882-e890. doi:10.4317/medoral.28313

BibTeX
@article{Seo2026,
  author = {Seo, H and Pak, H and Park, E and Son, J},
  title = {Clinical efficacy of recombinant human bone morphogenetic protein-2 loaded acellular dermal matrix for horizontal ridge augmentation},
  journal = {Medicina Oral Patología Oral y Cirugia Bucal},
  year = {2026},
  pages = {e882--e890},
  doi = {10.4317/medoral.28313}
}
Kostenlos starten →